Phonpen Akawatcharangura Goo

Name matching only

Publications

Citations

h-index

Computed over the works the graph holds, so it is a floor rather than a career figure.

i10-index

Publications

8 works in the graph, newest first.

The impact of multimorbidity on Quality of Life in inflammatory myopathies: A cluster analysis from the COVAD dataset
2024Lara D. VeekenJournalOpen access6 citations10.1093/rheumatology/keae520
Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-survey
2024Rheumatology Advances in PracticeJournalOpen access6 citations10.1093/rap/rkae028
Determinants of physical function, as measured using PROMIS PF-10a, in patients with rheumatoid arthritis: results from the international COVID-19 Vaccination in Autoimmune Diseases (COVAD) study
2024Rheumatology Advances in PracticeJournalOpen access1 citations10.1093/rap/rkae154
Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period—a cross-sequential study based on COVAD surveys
2023Lara D. VeekenJournalOpen access35 citations10.1093/rheumatology/kead144
Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys
2023Lara D. VeekenJournalOpen access18 citations10.1093/rheumatology/kead057
Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study
2023Lara D. VeekenJournalOpen access8 citations10.1093/rheumatology/kead149
Flares of autoimmune rheumatic disease following COVID ‐19 infection: Observations from the COVAD study
2023International Journal of Rheumatic DiseasesJournalOpen access7 citations10.1111/1756-185x.14961
POS0273 POST COVID-19 SYNDROME IN PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASES: RESULTS FROM THE COVAD STUDY
2023Annals of the Rheumatic DiseasesJournalOpen access1 citations10.1136/annrheumdis-2023-eular.4241